Answers are grounded in this paper and cite their sources.
People living with HIV (PLWH) face a significantly elevated risk of nontuberculous mycobacteria (NTM) infection, a major driver of morbidity and mortality. Given the regional variations and inconsistent evidence, this study aimed to evaluate the prevalence of NTM detection among PLWH worldwide. We systematically searched PubMed, Embase, Web of Science, and Cochrane Library for studies published up to May 2025. Pooled prevalence estimates were derived using a random-effects model with the Freeman-Tukey double arcsine transformation in STATA ® (version 15.0). Subgroup analyses, meta-regression, and sensitivity analyses were performed to explore sources of heterogeneity and assess the robustness of the results. A total of 67 studies involving 150,988 participants were included. The global pooled prevalence of NTM detection among PLWH was 5.5% (95% confidence interval [CI]: 4.4%–6.7%). Mycobacterium avium complex (MAC) was the most frequent species, with a prevalence of 5.6% (95% CI: 4.3%–7.1%). Regionally, prevalence was highest in Europe (7.1%) and Asia (6.3%), followed by North America (5.8%), Africa (4.4%), and Latin America and the Caribbean (2.1%). Notably, prevalence varied significantly across antiretroviral therapy (ART) eras: 7.2% (95% CI: 5.4%–9.1%) before 1996, 4.3% (95% CI: 2.8%–6.2%) during 1996–2010, and 3.7% (95% CI: 2.1%–5.8%) during the period of widespread highly active antiretroviral therapy (HAART) implementation after 2010 (P for trend across ART-era categories = 0.034), with the lowest estimate observed in the modern ART era. Pooled prevalence differed markedly between study-level baseline CD4 + T-cell strata: 6.7% (95% CI: 3.0%–11.7%) for the < 100 cells/µL stratum versus 1.2% (95% CI: 0.4%–2.4%) for the > 200 cells/µL stratum (meta-regression P = 0.001). However, substantial between-study heterogeneity (I² = 98.8%) warrants caution in generalizing this single global estimate, and the stratified estimates are more clinically informative. NTM detection remains common among PLWH, with MAC as the predominant species detected. Although prevalence is lowest in the modern ART era, NTM detection persists, and the markedly higher prevalence among studies of severely immunosuppressed populations (CD4 + counts below 100 cells/µL) may help target screening research in the future. It is urgently needed to develop rapid diagnostic techniques for early NTM detection. Not applicable.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: